| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |